A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall

29 August 2021 (08:11 - 08:22)
Organised by:
Congress Presentation Part of: Young Investigator Awards Session in Coronary Pathophysiology and Microcirculation Inflammation and Immunity ESC Premium Access ESC Congress 2021 - The Digital Experience

ESC 365 is supported by

ESC 365 is supported by